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ABSTRACT
Near-infrared (NIR) emissive organic materials are an emerging area of study with an array
of applications for both military and civilian purposes including night vision technologies,
secure communications, surveillance, homing, fluoresence imaging, secure displays as
NIR OLED materials, heat-blocking coatings, in vivo fluoresence biological imagaing, and
additional optoelectronics device applications.

We have developed a series of organic NIR emissive materials based on an indolizine
donor and squaraine acceptor. The novel-to-squaraine donor, indolizine, exhibits a
remarkable increase in absorption maximum wavelength when compared with benchmark
indoline-based squaraine dyes (700 nm vs. 625 nm) with molar absorptivities ranging from
100,000-262,000 M-1cm-1. Emission is observed at about 750 nm in chloroform,
corresponding to a stokes shift of 50 nm, which is a substantial increase when compared
with the 5 nm stokes shift commonly observed for indoline-squaraine dyes. Our molecular
design was evaluated by computational analysis which reveals clues about the origin of
this stokes shift and the water solubility observed for these compounds without appending
water solubilizing groups.
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Introduction.
Functional organic dyes have made many significant contributions to the
development of electronic and photonic devices recently, particularly in hi-tech photonbased technologies of electronics and optoelectronics. Due to their extremely tunable
properties, dyes used in these applications are at the forefront of many emerging
technologies. Of particular interest are near-infrared (NIR) emissive organic materials,
driven by their applications for both military and civilian purposes. Military applications
include night vision technology, secure communications, surveillance, homing,
fluorescence imaging, transparent photovoltaics, secure displays and heat-blocking
coating.1,2,3 Nonmilitary uses for NIR materials involve a number of important sectors,
such as energy conversion, in vivo fluorescence bioimaging, sensitizing and
optoelectronics.4,5

Figure 1. Jablonski diagram of an emissive process.
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For many applications, highly emissive materials are desirable. Fluorescence is the
luminescence that occurs when energy is supplied by electromagnetic radiation. This can
occur when a molecule in an excited state relaxes to its ground state, as illustrated in a
Jablonski diagram, shown in Figure 1.6 Figure 1 describes the absorption and emission of
a molecule, where the blue arrow represents the molecule being irradiated to an excited
state, the black arrow represents vibrational relaxation from a higher energy excited state
to S1, and the red arrow represents either fluorescence or phosphorescence to the singlet
ground state, S0. There are many other relaxation pathways that a molecule may undergo
to give non-radiative decay. The efficiency of fluorescence is described by fluorescence
quantum yield (Φ, Equation 1), which is a ratio of the photons absorbed resulting in the
emission of fluorescence to the total number of photons absorbed rate of fluorescence to
the rate of all relaxation pathways that the molecule may undergo.
𝜑=

𝑘𝑓
𝑘𝑓 + 𝑘𝑛𝑟

Equation 1. Fluorescence quantum yield, where kf is the rate of fluorescence and knr is the
rate of non-radiative decay.
Emissive materials may be further described by the wavelengths (λ) at which the
lowest energy maximum light absorption and maximum emission occurs, the difference of
which is known as the Stokes shift. When a molecule is excited, it often undergoes
conformational changes to become planar and allow free movement of electrons. The
molecule will undergo the same conformational changes to move from the completely flat,
planar excited state to the “twisted” ground state, increasing the difference between
absorption and emission wavelengths and giving a larger Stokes shift. However, the more
conformational changes that the molecule undergoes, the longer the relaxation time will
2

be. The longer relaxation time allows other non-radiative decays to kinetically compete,
decreasing the fluorescence quantum yield. These two characteristics must be balanced,
because if the Stokes shift is too narrow, emission wavelengths can be difficult to detect
over absorption wavelengths for many applications. Figure 2 illustrates a general
absorption and emission spectra with the difference of a Stokes shift indicated.7

Figure 2. General absorption and emission spectra indicating the Stokes shift of a
molecule.

Of particular interest for NIR emissive materials is their application for in-vivo
biological imaging, due to low tissue autofluoresence and high tissue light penetration in
the NIR spectrum window.8,9 Traditional modalities in molecular imaging employ ionizing
radiation with low sensitivity and poor resolution.10,11 NIR organic emissive molecules
provide an option of noninvasive molecular imaging, with high sensitivity to chemical
reagent and high target to background ratio, giving better visibility in imaging. One
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important parameter for NIR emissive materials in optical imaging is that fluorescence
events take place in an imaging window which is suitable to biological systems. This
window, referred to as the therapeutic window, ranges from λ = 650-900 nm,10,12,13 as seen
below in Figure 3.14

Figure 3. The therapeutic window for NIR emissive materials. HbO2 is oxygenated
hemoglobin and Hb is deoxygenated hemoglobin.

In this range of wavelengths, light absorption from water, melanin, proteins, and
hemoglobin within the biological system are at their lowest, as well as minimal tissue
autofluorescence occurs, allowing for deep penetration of light.15,16 Fluorescent dyes with
both absorption and emission within the therapeutic window are extremely desirable, as
even molecules with high fluorescence quantum yields that do not absorb and emit light
within this spectral range will have severely attenuated signals due to inadequate excitation
as a result of poor light penetration depth.
4

With the right chemical and spectral properties, organic fluorescent dyes are strong
candidates for biological imaging agents. This requires that the organic molecules have
intrinsic properties fitting to a biological system, including excitation and emission
wavelengths within the therapeutic window, a high fluorescence quantum yield and a high
absorption coefficient as well as good water solubility, Stokes shift, photostability and
chemical stability in different environments. Due to the limitations of many conventional
dyes, such as poor hydrophilicity, low quantum yields and insufficient stability, there are
few NIR dyes that meet these requirements. 17 The classes of dyes that are widely studied
for use in biological imaging include cyanines, phthalocyanines/porphyrin derivatives,
BODIPY (borondipyrrolmethane) analogues, and squaraines.12 Each class has its own
general advantages and disadvantages with typical values summarized in Table 1 below.

Organic Dyes

Absorption
range (nm)

Fluorescence
emission
range (nm)

Photostability

Molar extinction
coefficient (M-1
cm-1)

Fluorescence
quantum
yield (Φ)

Cyanines

400-800

500-800

Poor

~200,000

0.12-0.67

Phthalocyanines
/ Porphyrin
derivatives

350-800

350-800

High

~100,000

-

BODIPY
analogues

500-645

506-760

Very
high

~80,000

0.92

Squaraines

350-900

350-900

High

~300,000

0.1-0.86

Table 1. Emissive organic dyes and general spectral properties.
Cyanine dyes, characterized by two aromatic nitrogen containing heterocycles
connected with a polymethine bridge, have been studied extensively, are easily tunable to
5

the NIR region simply by extension of the methine bridge, and have strong absorption
coefficients at about 200,000 M-1cm-1.18,19,20 Most cyanine dyes exhibit low quantum yield
(ranging about 1% to 7%), which extension of the polymethine bridge lowers further. 21
One cyanine dye, known as Indocyanine Green (ICG) (shown in Figure 4) is the only
approved organic dye for medical diagnostics and has been FDA approved for over 50
years for direct administration, commonly used to track blood flow and clearance. 8,9,22
However, ICG is severely limited in biological applications due to its low quantum yield
of 1.2%, Stokes shift of ~5 nm and exceptionally low stability.23

Figure 4. Molecular structure of Indocyanine Green.
Phthalocyanines and porphyrin derivatives consist of four bridged pyrrole subunits
linked together through nitrogen atoms with a central cavity containing two hydrogen
atoms. They are thermally and chemically very stable, and can support intense
electromagnetic radiation.8 The central hydrogen atoms can be replaced with many metals,
which allows for fine-tuning of the dyes spectral properties. However, most
phthalocyanines and their derivatives still exhibit absorption and emission maxima below
700 nm, making their use for biological imaging very limited. Many phthalocyanines are
studied for use in photodynamic therapy (PDT), as the dye is selectively taken up in
6

malignant and dysplastic tissues and irradiated, the central metal atom generates reactive
singlet oxygen, which is cytotoxic to cells and can cause tumor death.8,12,22 However,
applications are limited due to requiring high energy absorption and tuning to utilize lower
energy light is synthetically challenging.
BODIPY (borondipyrrolemethene) dyes were originally discovered in 1968 by
Triebs and Kreuzer.24 They are thermally and chemically stable in physiological
conditions, with high quantum yield and sharp fluorescence emissions. Few BODIPY dyes
have emission maxima above 600 nm, making them again unsuitable for biological
imaging applications.25,26 Research to tune absorption range is ongoing for with many
research groups worldwide.
Squaraines consist of an oxycyclobutenolate core with aromatic or heterocyclic
components at both ends of the molecule and exhibit a resonance-stabilized zwitterionic
structure, shown in Scheme 1. Squaraines have extremely intense absorption bands, high
molar absorptivity, good fluorescent quantum yield and strong fluorescence in solution .27
However, they are typically planar and highly conjugated molecules resulting in
hydrophobic structures, and few emit in the NIR region.8 Sulfonated derivatives with
greatly increased water solubility and emission at about 800 nm have been reported by
Umezawa et al., but the process of sulfonation reduced quantum yield to about 8%
compared to non-sulfonated versions with a quantum yield of 44%.28 Nakazumi et al.
synthesized a series of bis-squaraines with pyrene or thiophene linkers and carboxyl end
groups that exhibit emission maxima between 750-790 nm, with quantum yield again
decreased to 0.01-1%. 29 We chose to target squaraines due to evidence for tunability with
a focus on water solubility, Stokes shift and high quantum yield in the therapeutic window.

7

Scheme 1. Resonance-stabilization of indolizine-squaraine dyes.

Squaraines are the dicondensation product of two electron-rich aromatic or
heterocyclic molecules (including N,N-dialkylanilines, benzothiazoles, phenols, azulenes
and pyrroles) with squaric acid.30 Substitution of the two donor units on zwitterionic
squaraine dyes changes the intrinsic properties of the molecule and results in a variety of
symmetric and unsymmetric squaraines with tunable optical properties. We have
developed a series of twelve NIR emissive materials based on an indolizine donor and
squaraine acceptor (bis(indolizine)-squaraine, or In-SQ), shown in Figure 5, which are of
interest for a host of applications including living fluorescent biological imaging. For this
application, the ideal material will (1) be water-soluble, (2) be stable in biological
environments, (3) target the therapeutic window by both absorbing and emitting light
between 650 and 900 nm, (4) have a relatively wide Stokes shift, (5) have strong adsorption
and (6) have high fluorescence quantum yield. Squaraine derivatives have been proven to
possess many of these characteristics, including intense absorption bands, high molar
absorptivity coefficients, and good photoconductivity. However, because of their large,
8

planar, π-conjugated systems, many squaraine derivatives remain water insoluble, have
poor Stokes shifts and have absorptions outside the therapeutic window. By using a
indolizine donor moiety, these characteristics can be adjusted. By substituting an indolizine
donor compared to the standard indoline donor, emission has been shown to red shift
dramatically by ~100 nm, while the Stokes shift increases and water solubility improves.
The shift in absorption wavelength can be justified by the generation of an proaromatic
stabilized pyridinium during electron donation, as can be seen in Scheme 1.

Figure 5. R-In-SQ series.
The benchmark bis(indoline)-squaraine (ISQ) molecule exhibits absorption and
emission maxima at about 650 nm with a Stokes shift of 5 nm.31 Our series of dyes have a
bis(indolizine)-squaraine (In-SQ) backbone, which is contrasted to ISQ in Figure 6.
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Figure 6. Comparison of ISQ and R-In-SQ dyes.

By making small modifications to the indolizine donor units, the absorption and
emission maxima can be red shifted into the therapeutic window. The bathochromatic shift
in absorption and emission spectra can be attributed to the increased electron density of the
indolizine donor subunit and to an induced twist angle on the bis(indolizine)-squaraine
molecular backbone compared to the completely flat, planar structure of ISQ, respectively.
This twist be seen in Figure 7. The induced twist angle has also led to a lower hydrophobic
shielding of the charged donor/squaraine core, which has led to an appreciable H2O
stability (fully miscible in a 1:1 H2O: MeOH mixture).

Figure 7. Computational study showing the twist angle of MeOPh-In-SQ.

We hypothesize that this novel donor system will improve upon presently used
donor moieties with wide-ranging applications. These molecules have demonstrated many
10

exciting characteristics, including water solubility resulting from sterically-induced
molecular twist angles and long-wavelength absorption and emission characteristics that
fall within the 650-900 nm range of the therapeutic window. Each of our materials has an
absorption maxima (λABS) of about 700 nm and emission maxima (λEMS) at about 750 nm,
indicating a Stokes shift of about 50 nm. These attributes, compared to the standard
indoline squarine material, which has a Stokes shift of 12 nm and is completely planar
(with poor solubility in water), are very promising for in vivo bioimaging.
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Results and Discussion.
General Synthesis of R-In-SQ dyes:
The synthesis of the R-In-SQ series follows 2-synthetic steps according to Scheme
2. The indolizine ring is formed by a cyclization reaction with commercially available ethyl
pyridine in a nucleophilic addition with a bromo-acetyl group in acetone, followed by
condensation with sodium bicarbonate and water. The resulting electron-rich indolizine
undergoes an electrophilic aromatic substitution with 0.5 equivalents of squaric acid to
form the di-substituted squaraine dye. Purifications for all dyes were completed through
recrystallization, without the use of silica gel chromatography.

Scheme 2. Synthetic scheme for R-In-SQ dye series. (a) i. ethyl-pyridine (1 equiv.), 0.5 M
acetone, 60°C, 12-22 hr.; ii. sodium bicarbonate (4 equiv.), 1 M H2O, 100°C, 2-7 hr.; 14%
12

(Me); 68% (Ph); 72% (MeOPh); 30% (Naph); 35% (OHPh); 92% (CF3Ph); 54% (CNPh);
23% (NO2Ph); 21% (bis-tBuPh); not isolated with high analytical purity (Mes, Py, bisCF3Ph);. (b) 3,4-dihydroxy-1,2-cyclobutanedione (0.5 equiv.), 0.035 M toluene, 0.035 M
n-butanol, 130°C, 2.25-24 hr.; 61% (Me); 82% (Ph); 58% (MeOPh); 70% (Mes); 86%
(Naph); 3% (Py); 95% (OHPh); 9% (CF3Ph); 90% (bis-CF3Ph); 25% (CNPh); 64%
(NO2Ph); 84% (bis-tBuPh).

Optical and Electrochemical Properties:
Making minor design changes to the ISQ structures yielded considerable effects on
the optical and electrochemical dye parameters, summarized in Table 1. The induced twist
angle produced by the indolizine donor caused a red shift in absorption and emission
observed in all the molecules. In addition, the Stokes shift was observed to increase in all
the molecules. Although the bis-2,4-substituted molecules exhibited high molar
absorptivities (216,000 M-1cm-1, bis-tBuPh-In-SQ; 260,000 M-1cm-1, bis-CF3Ph-In-SQ),
they also demonstrated slightly smaller Stokes shifts (21 nm, bis-tBuPh-In-SQ; 33 nm,
bis-CF3Ph-In-SQ).

No significant impact on quantum yield, λmax or λemis was

demonstrated due to presence of electron-donating or electron-withdrawing groups.
However, extension of the π-ring as in Py-In-SQ and Naph-In-SQ resulted in lower molar
absorptivity values (150,000 M-1cm-1 and 100,000 M-1cm-1, respectively) than for dyes
without extensive conjugation without any significant red-shift in absorption or emission
maxima or increase in Stokes shift. Highest quantum yields were observed in Py-In-SQ,
bistBuPh-In-SQ and bisCF3Ph-In-SQ at 12.2%, 9.5% and 5.4%, respectively. Lowest
quantum yield was observed in Mes-In-SQ, OHPh-In-SQ and Ph-In-SQ at 0.7%, 0.9%
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and 2.1%, respectively. There was no strong correlation between electron donating or
withdrawing groups and quantum yield, but the reduced quantum yield in Mes-In-SQ,
OHPh-In-SQ and Ph-In-SQ may be due to reduced solubility in solution. Generally, as
Stokes shift increased, quantum yields decreased with the one exception to this trend being
Py-In-SQ, with a quantum yield of 12.2% and Stokes shift of 48 nm. Cyclic voltammetry
measurements were made to analyze the influence of each indolizine donor on the
electronic properties of the dyes. As can be seen in Table 2, the presence of electronwithdrawing groups on the donor subunit slightly increases the E(S+/S) and E(S-/S) values on
the NHE scale (meaning these values are more stabilized energetically).

Table 2: UV-Vis-NIR absorbance and electrochemical data.
λemis

Dye
λmax
(R-In-SQ) (nm)

λonset
(nm)

(nm)

706
716
718a
720
722
716
716c
716
720
720
723
727
659

738
753
745a
756
752
750
755c
738
751
746
753
757
-

760
778
765 a
776
770
776
774c
737
773
753
777
778
671

Me
Ph
Mes
Naph
Py
MeOPh
OHPh
bistBuPh
CF3Ph
bisCF3Ph
CNPh
NO2Ph
ISQ

Stokes
ε
shift (M-1cm-1)
(nm)
52
210,000
62
181,000
47
262,000
56
150,000
48
100,000
60
140,000
58
185,000
21
216,000
53
166,000
33
260,000
54
213,000
51
185,000
12
229,000

Egopt
(eV)
1.68
1.65
1.66
1.64
1.65
1.65
1.64
1.68
1.65
1.66
1.65
1.64
-

E(S+/S)

E(S-/S)
[E(S2-/S-)]
(V)
(V)
1.32
-0.74
1.40
-0.84
1.33
-0.84
1.30
-0.80
1.26
1.27
-0.79
-0.71
1.30
-0.83
1.33
-0.71
1.44
-0.63
1.31
-0.70
1.34 [0.85] -0.64 [-0.93]
1.17
-1.10
[E(S2+/S+)]

E(S+/S*)
(V)

Quantum
Yield Φ

-0.36
-0.25
-0.33
-0.34
-0.39
-0.38
-0.38
-0.38
-0.32
-0.22
-0.34
-0.30
-

0.0212
0.0074
0.0412
0.1224
0.0296
0.0095
0.0948
0.0247
0.0539
0.0362
0.0340
-

Solvent is Toluene. a- solvent is dichloromethane. b- irreversible reduction. c-solvent is 1:1 DCM:DMSO. UV/Vis
spectra were measured with a Cary 5000 UV-Vis spectrometer with samples dissolved in dichloromethane. λonset values
were taken at the intercept of a tangent line on the low energy side of the max absorption curve and the baseline. The
optical bandgap (Egopt) was calculated according to the equation Egopt = 1240/ λonset. E(S+/S) and E(S-/S) measurements were
made in dichloromethane solution using a 0.1 M Bu 4NPF6 electrolyte and ferrocene as an internal standard. All values
are reported vs. NHE. E(S+/S*) values were calculated according to the equation E(S+/S*) = E(S+/S) – Egopt.
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Figure 8. UV-vis absorption and emission spectra of R-In-SQ series dyes. All
measurements were taken in dichloromethane solution.
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Figure 9. Cyclic voltammogram of Ph-In-SQ.
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Figure 10. Cyclic voltammogram of Py-In-SQ.
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Figure 11. Cyclic voltammogram of OHPh-In-SQ.
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Figure 12. Cyclic voltammogram of NO2Ph-In-SQ.
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Conclusion.
We have successfully synthesized a series of indolizine-squaraine dyes intended for
use in biological imaging. The R-In-SQ series of dyes were designed to incorporate an
indolizine donor analogous of ISQ. All dyes in the R-In-SQ series exhibited a red shift in
absorption and emission maximas well as an increased Stokes shift, as compared to ISQ.
Through synthesis of twelve squaraines in this series, we were able to study substituent
effects in addition to the change in donor from indoline to indolizine. A comparison of PyIn-SQ to ISQ shows a red shift in absorption maxima of ~60 nm (from 659 nm to 722 nm)
and an increased Stokes shift of ~35 nm. This bathochromatic shift effectively translocates
the absorption and emission of Py-In-SQ into the therapeutic window. The induced twist
angle from substituting an indolizine donor moiety on Py-In-SQ allows appreciable water
solubility through exposure of the charged squaraine core, compared to the insoluble ISQ.
The molar absorptivity of Py-In-SQ has decreased by about 50% compared to ISQ, yet is
still relatively high compared to other classes of organic emissive materials at 100,000 M1

cm-1. In addition, Py-In-SQ exhibited a quantum yield of 12% in solution, and squaraine

dyes are inherently stable. Based on these displayed characteristics, the R-In-SQ series of
dyes is promising for biological applications in particular and emissive materials in general.
Future studies will include analyzing the substituent effects of additional water-solubilizing
groups (such as sulfonated derivatives) to increase water solubility further.
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Experimental Procedures.
General Information
All commercially obtained reagents were used as received. Thin-layer chromatography
(TLC) was conducted with Uniplate pre-coated Alumina GF or Sigma T-6145 pre-coated
Silica gen 60 F254 polyester sheets and visualized with UV. Flash column chromatography
was performed as described by Still using Sorbent Tech P60, 40-63 μm (230-400 mesh).
1

H NMR spectra were recorded on a Bruker Avance-300 (300MHz) spectrometer and a

Bruker Avance-500 (500MHz) spectrometer and are reported in ppm using solvent as an
internal standard (CDCl3 at 7.26 ppm). Data reported as s = singlet, d = doublet, t = triplet,
q = quartet, p = pentet, m = multiplet, br = broad, ap = apparent, dd = doublet of doublets,
dt = doublet of triplets; coupling constant(s) in Hz; integration. UV-Vis Spectra were
measured with a Cary 5000 UV-Vis Spectrometer with samples dissolved in
dichloromethane unless otherwise noted. Cyclic voltammetry was measured with a C-H
Instruments electrochemical analyzer.

Synthetic Procedures: Me-In-SQ

O
(a)

N

N
N

(b)

N

(c)

O
O
N

1,2-dimethylindolizine (1): In a nitrogen filled round bottom flask equipped with
N

a stir bar and a reflux condenser 2-ethylpyridine (2.00 g, 18.7 mmol) was mixed

with chloroacetone (1.72 g, 18.7 mmol). The mixture was degassed with N2 for 20 minutes,
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then heated to 130°C for 24 hours. The product was extracted with excess ethyl acetate and
2 M KOH and dried with sodium sulfate. The product was purified through aluminum
oxide chromatography with 500 mL hexanes to yield the pure product (0.386 g, 14%). 1H
NMR (300MHz, CDCl3) δ 7.76 (d, J = 10.0 Hz, 1 H), δ 7.235 (d, J = 5.0 Hz, 1 H), δ 7.10
(s, 1 H), δ 6.545 (t, J = 7.5 Hz, 1 H), δ 6.325 (t, J = 7.5 Hz, 1 H), δ 2.26 (s, 6 H).

(Z)-4-(1,2-dimethyl-3H-indolizin-4-ium-3-ylidene)-2-(1,2N

dimethylindolizin-3-yl)-3-oxocyclobut-1-en-1-olate (2): In a flame

O

dried round bottom flask equipped with a stir bar and reflux
O
N

condenser, (1) (0.34 g, 2.34 mmol) was added with 3,4-dihydroxy1,2-cyclobutanedione (0.12 g, 1.05 mmol), and degassed under N2 for

10 minutes. The mixture was dissolved in 0.035 M dry, degassed toluene and 0.035 M dry
n-butanol and refluxed for 20 hours. The reaction mixture was cooled to room temperature,
and 500 mL diethyl ether was added to crash out a green solid. The liquid was decanted to
yield the pure product (0.24 g, 61% ). 1H NMR (300 MHz, CDCL3) δ 10.36 (d, J = 6.78
Hz, 2 H), δ 7.28 (2 H), δ 7.15 (t, J = 7.05 Hz, 2 H), δ 6.85 (t, J = 6.37 Hz, 2 H), δ 2.81 (s,
6 H), δ 2.21 (s, 6 H).

13

C NMR (300 MHz, CDCl3) unable to collect, product will not

readily dissolve into an appropriate solvent. IR (neat, cm-1): 3392.1 (br),1625.7, 1623.7.
UV-vis (CH2Cl2) λmax = 706 nm (ε = 77,825 M-1cm-1), λonset = 740 nm.
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Synthetic Procedures: Ph-In-SQ

N
O

N
+

Br

(b)

(a)

O
O

N
N

1-methyl-2-phenylindolizine (4): To a round bottom flask equipped with a
stir bar and a reflux condenser was added 2-ethylpyridine (2.0 g, 18.7 mmol),
N

2-bromo-1-phenylethanone (3.72 g, 18.7 mmol) and 56.6 mL acetone. The
reaction mixture was heated to 60°C and stirred. After 20 hours, the reaction mixture was
cooled to room temperature and a white precipitate formed. The precipitate was filtered
and washed with 5 mL cold acetone, then transferred to a round bottom flask equipped
with a stir bar and reflux condenser and dissolved in 100 mL water with sodium bicarbonate
(6.72g, 75 mmol). The solution was heated to 100°C and allowed to stir. After 7 hours, the
reaction mixture was cooled to room temperature and dark oil crystallized on top of the
water layer. The oil crystals were filtered and allowed to dry to yield the pure product (2.64
g, 68%). 1H NMR (500 MHz, CDCl3) δ 7.85 (dt, J = 7.0 Hz, 0.9 Hz, 1 H), δ 7.54 (d, J =
7.7 Hz, 1 H), δ 7.45 (7, J = 7.4 Hz, 1 H), δ 7.39 (s, 1 H), δ 7.35-7.29 (m, 2 H), δ 6.61 (ddd,
J = 7.1 Hz, 6.4 Hz, 1.0 Hz, 1 H), δ 6.42 (t, J = 6.8 Hz, 1 H), δ 2.45 (s, 3 H).
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(Z)-4-(1-methyl-2-phenyl-3H-indolizin-4-ium-3-ylidene)-2N

(1-methyl-2-phenylindolizin-3-yl)-3-oxocyclobut-1-en-1-olate

O

(5): To a flame dried round bottom flask equipped with a stir bar
O

and reflux condenser was added (4) (0.50 g, 2.4 mmol), and 3,4-

N

dihydroxy-1,2-cyclobutanedione (0.137 g, 1.20 mmol) then
degassed under N2 for 10 minutes. The mixture was dissolved in 136 mL 1:1 toluene:nbutanol then heated to 130°C for 15 hours. The mixture was cooled to room temperature,
extracted with dichloromethane and washed three times with water. The product was
purified

through

alumina

chromatography

with

a

gradient

of

75:25

dichloromethane:hexanes then 98:2 dichloromethane:methanol and recrystallized in
acetone and dichloromethane to yield a green solid (0.49 g, 82%). 1H NMR (500 MHz,
CDCL3) δ 10.069 (d, J = 6.90 Hz, 2 H), δ 7.49-7.43 (m, 6 H), δ 7.39-7.35 (m, 6 H), δ 7.21
(t, J = 5.00 Hz, 2 H), δ 6.875 (t, J = 7.50, 2 H), δ 2.175 (s, 6 H).

13

C NMR (300MHz,

CDCl3) δ 175.6, 168.5, 141.4, 137.5, 134.9, 134.7, 130.5, 127.6, 127.5, 126.8, 120.6, 118.2,
117.0, 114.9, 77.6, 77.2, 76.8, 9.5. IR (neat, cm-1): 3401.7 (br), 2356.5, 2329.5, 2038.3,
1633.4, 1616.0. HRMS m/z calculated for C34H24N2O2 [M+H]+: 493.1916, found 493.1962.
UV-vis (CH2Cl2) λmax = 716 nm (ε = 180,618 M-1cm-1), λonset = 753 nm.

Synthetic Procedures: Mes-In-SQ

O

+

Cl

(a)

Br

O
Br

(b)

N

24

O

(c)

N

N

O

2-bromo-1-mesitylethanone (6): In a round bottom flask equipped

O
Br

with a stir bar, mesitylene (10 mL, 96.4 mmol) was added and cooled to
0°C. After 10 minutes, aluminum trichloride (1.7 g, 13 mmol) was added and allowed to
cool for 5 minutes. 2-bromoacetyl chloride was added drop wise (6.00 mL, 72.0 mmol).
The solution turned from yellow to orange, and was stirred while warming to room
temperature for 15 hours. The reaction mixture was then poured into 100 mL cold H2O and
extracted twice with 150 mL Et2O. The organic layer was washed with 50 mL saturated
sodium bicarbonate, dried with magnesium sulfate, filtered and concentrated to yield the
pure product (16.4 g, 94%). 1H NMR (300 MHz, CDCL3) δ 6.90 (s, 2H), δ 4.29 (s, 1 H), δ
2.32 (s, 3 H), δ 2.26 (s, 6H).

2-mesityl-1-methylindolizine (7): To a round bottom flask equipped with a
stir bar and a reflux condenser was added (6) (2.41 g, 10 mmol) and 2-ethyl
N

pyridine (1.14 mL, 10 mmol) and dissolved in 0.5 M acetone (20 mL). The
mixture was heated to 60°C for 21 hours, in which no product was observed.

The reaction mixture was then concentrated, dissolved in 20 mL acetone and heated to
150°C for 24 hours, then cooled to room temperature and poured into a 100 mL round
bottom flask, dissolved in 70 mL H2O and sodium bicarbonate (3.5 g, 40 mmol). The
mixture was heated to 100°C for 2 hours, then cooled to room temperature, extracted with
dichloromethane and concentrated. The product was passed through 200 mL SiO2 using
30:70 hexanes:dichloromethane and concentrated to yield a mixture of (6) and (7), which
was carried through to the next step. 1H NMR (300 MHz, CDCL3) δ 8.535 (d, J = 5.0 Hz,
1 H), δ 7.615 (t, J = 7.5 Hz, 1 H), δ 7.18 (d, J = 10.0 Hz, 1 H), δ 7.615 (t, J = 7.5 Hz, 1 H),
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δ 7.115 (d, J = 7.5 Hz, 1 H), δ 6.88 (s, 2 H), δ 6.81 (s, 1 H), δ 2.31 (s, 3 H), δ 2.24 (s, 6 H),
δ 2.29 (s, 3 H).

(Z)-4-(2-mesityl-1-methyl-3H-indolizin-4-ium-3-ylidene)-2-(2-mesityl-1O

N

methylindolizin-3-yl)-3-oxocyclobut-1-en-1-olate) (8): To a
flame dried, round bottom flask equipped with a stir bar and a

N

O

reflux condenser under N2, (7) (0.10 g, 0.40 mmol) was

dissolved in 4 mL 1:1 toluene:n-butanol. 3,4-dihydroxy-1,2-cyclobutanedione (0.021 g,
0.18 mmol) was added and the mixture was heated to reflux for 1.5 hours, cooled to room
temperature and concentrated to yield a red solid. The solid was suspended in diethyl ether,
centrifuged, and the supernatant was decanted. The resulting solid was washed with
hexanes (10 mL, 3 times) and dried to yield a bronze/red metallic solid (0.08 g, 70%). 1H
NMR (300 MHz, CDCL3) δ 10.1268 (d, J = 6.84 Hz, 2 H), δ 7.3103 (d, J = 8.70 Hz, 2 H),
δ 7.1476 (t, J = 6.871 Hz, 2 H), δ 6.9335 (s, 4 H), δ 6.8335 (t, J = 6.81 Hz, 2 H), δ 2.3829
(s, 6 H), δ 1.9717 (s, 12 H), δ 1.983 (s, 6 H).

13

C NMR will not readily dissolve into

solution. IR (neat, cm-1): 3411.3903 (br), 1635.3074, 1616.0232. HRMS m/z calculated for
C34H24N2O2 [M+H]+: 577.2855, found 577.3189. UV-vis (CH2Cl2) λmax = 718 nm (ε =
261,581 M-1cm-1), λonset = 745 nm.
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Synthetic Procedures: Naph-In-SQ

(b)

(a)

N

N

O

+

N

O

N

O

Br

1-methyl-2-(naphthalene-2-yl)indolizine (9): To a flame dried, N2 filled
round bottom flask equipped with a stir bar and a reflux condenser was added
2-ethyl pyridine (0.215 g, 2.01 mmol), 2-bromo-2-(naphthalene-2-yl)ethan-1N

one (0.5 g, 2.01 mmol) and 8 mL acetone. The solution was heated to 60°C and
stirred. After 16 hours, a white precipitate had formed and the solution was

cooled to room temperature. The precipitate was filtered and washed with cold acetone,
then combined with sodium bicarbonate (0.086 g, 8.04 mmol) and dissolved in 32 mL
water. The mixture was heated to 100°C under reflux. After 2 hours, a brown solid had
formed. The solid was extracted with dichloromethane, washed three times with water,
dried and concentrated to yield the pure product (0.153 g, 30%). 1H NMR (300 MHz,
CDCl3) δ 7.96 (s, 1 H), δ 7.82-7.91 (m, 4 H), δ 7.68 (d, J = 8.25 Hz, 1 H), δ 7.42-7.53 (m,
3 H), δ 7.35 (d, J = 8.91, 1 H), δ 6.63 (t, J = 6.09 Hz, 1 H), δ 6.44 (t, J = 6.60 Hz, 1 H), δ
2.51 (s, 3 H). 13C NMR (300 MHz, CDCl3) δ 133.7, 133.5, 132.1, 131.1,129.0, 127.9 (2
C), 127.7, 127.4, 126.9, 126.1, 125.5, 124.8, 117.6, 115.8, 110.2, 110.1, 105.8, 9.8. IR
(neat, cm-1): 3050, 2965, 2919, 2860, 1626, 1598.
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(Z)-4-(1-methyl-2-(naphthaneln-2-yl)-3H-indolizin-4N

O

ium-3-ylidene)-2-(1-methyl-2-(naphthalene-2yl)indolizin-3-yl)-3-oxocyclobut-1-en-1-olate (10): To a

O

N

round bottom flask equipped with a stir bar and reflux
condenser was added (9) (0.103 g, 0.401 mmol) and 3,4-dihydroxy-1,2-cyclobutanedione
(0.013 g, 0.18 mmol), and flushed with N2 for 10 minutes. The solids were then dissolved
in 23 mL 1:1 toluene:n-butanol, and heated to 130°C for 2.25 hours during which a red
precipitate formed. The mixture was cooled to room temperature, 50 mL diethyl ether was
added and the liquid was decanted from the precipitate. To purify, the solids were dissolved
in dichloromethane and recrystallized three times, then suspended in diethyl ether and
centrifuged to yield a metallic red solid (0.102 g, 86%). 1H NMR (300 MHz, CDCl3) δ
7.77-7.90 (m, 2 H), δ 7.63-7.77 (m, 2 H), δ 7.40-7.56 (m, 3 H), δ 7.36 (d, J = 7.9 Hz, 1 H),
δ 7.17 (t, J = 7.7 Hz, 1 H), δ 6.79 (t, J = 6.42 Hz, 1 H).

13

C NMR will not dissolve into

solution. IR (neat, cm-1): 1600-3350 (br), 1594. UV-vis (CH2Cl2) λmax = 720 nm (ε =
149,649 M-1cm-1), λonset = 756 nm.

Synthetic Procedures: Py-In-SQ
O
Br
(a)

O

+

Cl

(b)

(c)

O

Br
N
N
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O

N

2-bromo-1-(pyren-4-yl)ethanone (11): In a flame dried round bottom

O
Br

flask equipped with a stir bar under N2, aluminum trichloride (0.34 g, 2.97
mmol) was suspended in 2 mL dichloromethane and cooled to 0°C. 2bromoacetyl chloride (0.215 mL, 2.60 mmol) was added slowly, then
pyrene (0.50 g, 2.47 mmol) was added. The solution turned a deep red and was warmed to
room temperature while stirring. After 3.5 hours, the mixture was diluted with 50 mL
dichloromethane and washed with 25 mL H2O. The organic layer was separated, then dried
with magnesium sulfate, filtered and concentrated to yield the pure product (0.77 g,
96%).1H NMR (500 MHz, CDCl3) δ 8.16 (d, J = 9.39 Hz, 1 H), δ 7.17-7.53 (m, 8 H), δ
4.71 (s, 2 H).

1-methyl-2-(pyren-2-yl)indolizine (12): In a round bottom flask equipped
with a stir bar and a reflux condenser, (11) (0.75 g, 2.32 mmol) and 2ethylpyridine (0.27 mL, 2.32 mmol) were dissolved in 10 mL acetone and
N

heated to reflux. After 19 hours, the reaction mixture was cooled to room
temperature and concentrated, then dissolved in 10 mL H2O with sodium

bicarbonate (0.78 g, 9.28 mmol) and heated to reflux for 3 hours. The solution was cooled
to room temperature, then extracted with 100 mL dichloromethane, dried with magnesium
sulfate, filtered and concentrated. 1H NMR (500 MHz, CDCl3) δ 8.38 (d, J = 10.0 Hz, 1
H), δ 7.87-8.23 (m, 9 H), δ 7.46 (s, 1 H), δ 7.44 (d, J = 5.0 Hz, 1 H), δ 6.71 (t, J = 5.0 Hz,
1 H), δ 6.48 (t, J = 7.5 Hz, 1 H), δ 2.31 (s, 3 H).
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(Z)-4-(1-methyl-2-(pyren-2-yl)-3H-indolizin-4-ium-3ylidene)-2-(1-methyl-2-pyren-2-yl)indolizin-3-yl)O
N

O

N

oxocyclobut-1-en-1-olate (13): To a flame dried round bottom
flask equipped with a stir bar and dean-stark apparatus under N2,
(12) was added and dissolved in 10 mL 1:1 toluene:n-butanol,
then heated to reflux. After 3 hours, the reaction mixture was

cooled to room temperature, the liquid was decanted from the mixture and a mixture of
diethyl ether/hexanes was added to precipitate a green solid. The mixture was centrifuged
and the resulting supernatant was decanted. To purify, 10 mL diethyl ether was added to
the solid, centrifuged and decanted three more times, then the green solid was subjected to
alumina oxide flash chromatography using 50% ethyl acetate / hexanes, concentrated, and
dissolved in dichloromethane. Hexanes were added to the dichloromethane solution until
a precipitate formed, then heated to reflux with a heat gun until the dichloromethane had
evaporated. The solution was concentrated, and then dissolved in dichloromethane,
precipitated by hexanes, refluxed and concentrated two more times to yield a blue/bronze
metallic product (0.030 g, 3%). Rotomers present, 1H NMR taken at variable temperature
(T = 300 K, T = 345 K) to observe peak changes. 1H NMR (300 MHz, CDCL3) δ 9.967 (br
s, 0.6 H), δ 9.549 (br s, 0.4 H), δ 8.3-7.8 (m, 6.2 H), δ 7.73 (d, J = 8.5 Hz, 0.7 H), δ 7.57.26 (m, 2.3 H), δ 7.25-7.0 (m, 1.8 H), δ 6.691 (br s, 0.6 H), δ 6.459 (br s, 0.4 H). 13C NMR
rotomer issue. IR (neat, cm-1): 2998.7066 (br), 1606.3811. HRMS m/z calculated for
C54H32N2O2 [M+H]+: 741.2542, found 741.1421. UV-vis (CH2Cl2) λmax = 722 nm (ε =
100,391 M-1cm-1), λonset = 752 nm.
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Synthetic Procedures: MeOPh-In-SQ
O

O

O

(a)

N

(b)

N

O

+

O
Br

N

N

O
O

O

2-(4-methoxyphenyl)-1-methylindolizine (14): To a round bottom flask
equipped with a stir bar and reflux condenser, 2-ethylpyridine (4.99 mL,
43.64 mmol) and 2-bromo-1-(4-methoxyphenyl)ethanone (10.0 g, 43.64

N

mmol) were dissolved in 44 mL acetone and refluxed for 24 hours to yield
a black precipitate. The precipitate was filtered, washed with cold acetone

and allowed to dry. The solid was then added to a flask equipped with a stir bar and reflux
condenser, dissolved in 88 mL H2O with sodium bicarbonate (14.5 g, 174.6 mmol) and
refluxed. After 2 hours, the mixture was cooled to room temperature to give a solid
precipitate. The liquid was decanted, then the solid was dissolved in dichloromethane, dried
with magnesium sulfate and filtered, subjected to SiO2 chromatography with 4000 mL 1:1
ethyl acetate:dichloromethane and condensed to yield the pure product (7.44 g, 72%). 1H
NMR (300 MHz, CDCL3) δ 7.8350 (d, J = 6.93 Hz, 1 H), δ 7.4474 (d, J = 6.69 Hz, 2 H),
δ 7.3354 (s, 1 H), δ 7.3042 (d , J = 9.30 Hz, 1 H), δ 7.4762 (d, J = 8.79 Hz, 2 H), δ 6.5929
(t, J = 7.32 Hz, 1 H), δ 6.3935 (t, J = 6.63 Hz, 1 H), δ 3.8558 (s, 3 H), δ 2.4080 (s, 3 H).
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(Z)-4-(2-(4-methoxyphenyl)-1-methyl-3H-indolizin-4-ium-

O

3-ylidene)-2-(2-(4-methoxyphenyl)-1-methylindolizin-3-yl)-

N

O

3-oxocyclobut-1-en-1-olate (15): To a flame dried round
N

O

bottom flask equipped with a stir bar and dean stark apparatus
O

under N2 was added (14) (0.16 g, 0.69 mmol) and 3,4-

dihydroxy-1,2-cyclobutanedione (0.04 g, 0.35 mmol). The mixture was degassed with N2
for 10 minutes, then dissolved in 20 mL 1:1 toluene:n-butanol and heated to 130°C with
stirring. After 6 hours, the reaction mixture was condensed, dissolved in dichloromethane,
washed with 50 mL H2O three times, dried with magnesium sulfate and condensed to yield
a metallic dark green solid (0.11 g, 58%). 1H NMR (300 MHz, CDCL3) δ 10.0991 (d, J =
6.78 Hz, 2 H), δ 7.3440 (d, J = 8.73 Hz, 2 H), δ 7.2501 (d, J = 5.94 Hz, 4 H), δ 7.1774 (t,
J = 7.14 Hz, 2 H), δ 6.9676 (d, J = 8.61 Hz, 4 H), δ 6.8551 (t, J = 6.51 Hz, 2 H), δ 3.8664
(s, 6 H), δ 2.1881 (s, 6 H). 13C NMR (300 MHz, CDCl3) δ 175.8547, 168.2807, 159.1101,
141.5192, 137.3907, 134.9318, 131.7630, 127.0735, 126.8220, 120.7107, 117.9745,
116.9169, 114.7445, 113.1887, 77.6565, 77.2335, 76.8099, 55.3494, 9.6079. IR (neat, cm1

): 3395.9628 (br), 1633.3791 (s). HRMS m/z calculated for C36H28N2O4 [M+H]+:

553.2127, found 553.21. UV-vis (CH2Cl2) λmax = 716 nm (ε = 139,513 M-1cm-1), λonset =
750 nm.
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Synthetic Procedures: OHPh-In-SQ

(a)

N

HO

OH

OH

(b)

N

O

+

O
Br

N

N

O
OH

OH

4-(1-methylindolizin-2-yl)phenol (16): To a flame dried round bottom flask
equipped with a stir bar and a reflux condenser was added 2-bromo4’hydroxyacetophenoe (1.00 g, 4.65 mmol), 2-ethyl pyridine (0.498 g, 4.65

N

mmol) and dissolved in 18.6 mL acetone. The mixture was heated to 60°C
and stirred during which a fine white precipitate formed. After 18 hours, the mixture was
cooled to room temperature and the precipitate was filtered off and washed with cold
acetone. The precipitate was then added with sodium bicarbonate (1.56 g, 18.6 mmol) and
18.6 mL water to a round bottom flask, and the mixture was heated and stirred for 2 hours.
After 2 hours, a dark brown oil had formed. The oil was extracted with dichloromethane,
washed 3 time with 50 mL water, dried with sodium sulfate and condensed to yield an
orange solid (0.356 g, 35%). 1H NMR (300 MHz, CDCl3) δ 7.76 (d, J = 6.96, 1 H), δ 7.33
(d, J = 8.46, 2 H), δ 7.21 (d, J = 9.87, 1 H), δ 6.84 (d, J = 8.49, 2 H), δ 6.53 (t, J = 7.72, 1
H), δ 6.32 (t, J = 6.66, 1 H), δ 4.8 – 5.1 (br s, 1 H), δ 2.34 (s, 3 H). 13C NMR (300 MHz,
CDCl3) δ 154.2, 130.9, 129.9, 128.72, 128.69, 124.7, 117.4, 115.6, 115.4, 109.9, 109.5,
105.4, 9.6. IR (neat, cm-1): 3309.2, 1619.9, 1608.3.
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(Z)-4-(2-(4-hydroxyphenyl)-1-methyl-3H-indolizin-4-ium-3-

HO

ylidene)-2-(2-(4-hydroxyphenyl)-1-methylindolizin-3-yl)-3-

N

O

oxocyclobut-1-en-1-olate (17): In a round bottom flask
O

N

equipped with a stir bar and a reflux condenser was added (16)
OH

(0.326 g, 1.46 mmol), 3,4-dihydroxy-1,2-cyclobutanedione (0.075 g, 0.657 mmol) and
dissolved in 80 mL 1:1 toluene:n-butanol. The mixture was heated to 130°C and stirred.
After 6 hours, the reaction mixture was condensed, dissolved in dichloromethane, washed
with 50 mL H2O three times, dried with magnesium sulfate and condensed to yield the pure
product. 1H NMR (300 MHz, DMSO) δ 9.92 (d, J = , 2 H), δ 9.48 (s, 2 H), δ 7.72, (d, J =
9.15 Hz, 2 H), δ 7.43, (t, J = 7.20 Hz, 2 H), δ 7.14 (d, J = 8.58 Hz, 4 H), δ 7.11 (t, J = 6.46
Hz, 2 H), δ 6.82 (d, J = 8.55 Hz, 4 H), δ 2.21 (s, 6 H). 13C NMR (300 MHz, CDCl3) δ will
not dissolve into solution. IR (neat, cm-1): 3397.89, 1641.09, 1639.16. UV-vis (CH2Cl2)
λmax = 716 nm (ε = 184,982 M-1cm-1), λonset = 755 nm.

Synthetic Procedures: bistBuPh-In-SQ

(a)

N

HO

OH

OH

(b)

N

O

+

O
Br

N

N

O
OH

OH

2,6-di-tert-butyl-4-(1-methylindolizin-2-yl)phenol (18): To a flame
dried round bottom flask equipped with a stir bar and a reflux condenser
was added 2-ethylpyridine (0.137 mL, 1.2 mmol), 2-bromo-1-(3,5-di-tert-

N

butyl-4-hydroxy-phenyl)-ethanone (.393 g, 1.2 mmol) and 1.6 mL
34

acetone. The reaction mixture was heated to 65°C for 12 hours, then cooled to 0°C. The
resulting precipitate was filtered and washed with cold acetone, then suspended in 2 mL
H2O. Sodium bicarbonate was added (0.403 g, 4.8 mmol), then the mixture was heated to
110°C for 2 hours. The mixture was cooled to room temperature, extracted with
dichloromethane, washed 3 times with water and dried with sodium bicarbonate and
concentrated to yield the pure product (.083 g, 21%). 1H NMR (500 MHz, CDCL3) δ
7.8381 (br s, 1 H), δ 7.25-7.40 (m, 4 H), δ 6.5817 (br s, 1 H), δ 6.3835 (br s, 1 H), δ 5.1815
(s, 1 H), δ 2.4220 (s, 3 H), δ 1.4921 (s, 18 H). 13C NMR (300 MHz, CDCL3) δ 152.8, 136.0,
131.1, 130.2, 127.2, 125.7, 124.8, 117.5, 115.6, 109.9, 109.6, 105.5, 77.6, 77.2, 76.8, 34.6,
30.6, 9.9. IR (neat, cm-1): 3627.37429 (s), 2942.424263, 2908.0704, 2863.8765. HRMS
m/z calculated for C23H29NO [M+H]+: 336.2327, found 336.2327.

(Z)-4-(2-(3,5-di-tert-butyl-4-hydroxyphenyl)-1-methyl-

HO

3H-indolizin-4-ium-3-ylidene)-2-(2-(3,5-di-tert-butyl-4-

N

O

hydroxyphenyl)-1-methylindolizin-3-yl-3-oxocyclobut-1N

O

en-1-olate (19): To a flame dried round bottom flask
OH

equipped with a stir bar and a reflux condenser was added (18) (69.0 mg, 0.206 mmol),
3,4-dihydroxy-1,2-cyclobutanedione (10.5 mg, 0.0925 mmol), n-butanol (5.88 mL), and
toluene (5.88 mL). The reaction was heated to 130°C for 15 hours, then cooled to room
temperature. The reaction was extracted with dichlorormethane, washed three times with
water and dried with magnesium sulfate. The product was purified through silica gel
chromatography in dichloromethane, and then triturated in ethyl acetate to give a red solid.
1

H NMR (300 MHz, CDCl3) δ 9.90 (d, J = 6.90 Hz, 1H), 7.37 (d, J = 8.61 Hz, 1H), 7.21
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(s, 1H), 7.16 (d, J = 8.73, 1H), 6.77 (t, J = 6.21 Hz, 1H), 5.29 (d, J = 3.36 Hz, 1H), 2.32 (s,
3H) 1.48 (s, 18H). 13C NMR not possible, will not dissolve into solution. IR (neat, cm-1):
3419.1040 (br), 1652.6634. HRMS m/z calculated for C50H56N2O4 [M]: 748.4240, found
748.4153. UV-Vis (CHCl3): λmax = 716 nm (ε = 216,101 M-1cm-1), λonset = 738.

Synthetic Procedures: CF3Ph-In-SQ

F

F

F

F

F

F

F F

F
(b)

(a)

N

O

N

+

N

N

O

F

Br

F

F

F

O
F F

1-methyl-2-(4trifluoromethyl)phenyl)indolizine (20): To a flame dried, round
bottom flask equipped with a stir bar and a reflux condenser, 2-ethyl pyridine
(1.07 mL, 9.33 mmol) and 2-bromo-1-(4-(trifluoromethyl)-phenyl)ethanone

N

(2.49 g, 9.33 mmol) were dissolved in 20 mL acetone and heated to reflux. After

22 hours, the reaction mixture was cooled to room temperature and concentrated. The
resulting solid was dissolved in 20 mL H2O and sodium bicarbonate (3.13 g, 37.3 mmol).
The mixture was refluxed for 2 hours and cooled to room temperature during which dark
crystals formed. The crystals were filtered and washed with cold water to yield the pure
product (2.36 g, 92%). 1H NMR (500 MHz, CDCl3) δ 7.855 (d, J = 6.00 Hz, 1 H) ,δ 7.671
(d, J = 8.00 Hz, 2 H), δ 7.624 (d, J = 8.0 Hz, 2 H), δ 7.414 (s, 1 H), δ 7.339 (d, J = 9.0 Hz,
1 H), δ 6.639 (t, J = 6.50 Hz, 1 H), δ 6.447 (t, J = 6.50 Hz, 1 H). 13C NMR (300 MHz,
CDCl3) δ 149.00, 139.88, 136.52, 131.27, 128.65, 127.53, 125.36, 124.81, 117.64, 116.15,
36

110.58, 110.13, 105.679.64. IR (neat, cm-1): 3399.8197 (br), 3070.0584, 2919.6409,
1683.5182, 1616.1241. HRMS m/z calculated for C16H12F3N [M+H]+: 276.1000, found
276.1318.

F

F F

(Z)-4-(1-methyl-2-(4-(trifluoromethyl)phenyl)-3HO

indolizin-4-ium-3-ylidene)-2-(1-methyl-2-(4-

N

trifluoromethyl)phenyl)indolizin-3-yl)-3-oxocyclobutN

O
F
F F

1-en-1-olate (21): To a flame dried, round bottom flask
equipped with a stir bar and condenser under N2, (20) (0.10

g, 0.36 mmol) and 3,4-dihydroxy-1,2-cyclobutanedione (0.021 g, 0.18 mmol) were
dissolved in 4 mL 1:1 toluene:n-butanol and heated to reflux. After 24 hours, the reaction
mixture was cooled to room temperature and a dark green precipitate formed. Diethyl ether
was added and a metallic yellow/bronze precipitate was observed. The mixture was
centrifuged and the resulting supernatant was decanted. To purify, diethyl ether was again
added to the precipitate, centrifugued and the supernatant was decanted 2 additional times.
Then, the precipitate was washed with hexanes to yield a metallic green solid (0.01 g, 9%).
1

H NMR (300 MHz, CDCL3) δ 10.141 (d, J = 6.90, 2 H), δ 7.653 (d, J = 8.40 Hz, 4 H), δ

7.408 (d, J = 8.10 Hz, 4 H), δ 7.3935 (d, J = 7.50 Hz, 2 H), δ 7.241 (t, J = 6.75 Hz, 2 H),
δ 6.924 (t, J = 6.90 Hz, 2 H), δ 2.163 (s, 6 H). 13C NMR (300 MHz, CDCL3) δ 141.540,
138.440, 136.093, 135.043, 130.905, 129.787, 129.385, 127.543, 122.928, 120.625,
118.953, 117.340, 115.595, 9.558. IR (neat, cm-1): 3380.5354 (br), 1616.0232. HRMS m/z
calculated for C36H22F6N2O2 [M]: 628.1585, found 628.1810. UV-vis (CH2Cl2) λmax = 720
nm (ε = 166,402 M-1cm-1), λonset = 751 nm.
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Synthetic Procedures: bisCF3Ph-In-SQ

(b)

CF3 (a)

F3 C

N

CF3

CF3

F3 C

F3 C

N

O

+

N

N

O

F3 C

Br

CF3

F3 C

CF3

O

2-(3,5-bis(trifluoromethyl)phenyl)-1-methylindolizine (22): To a
flame dried round bottom flask equipped with a stir bar and a reflux

N

condenser

was

added

1-(3,5-bis(trifluoromethyl)phenyl)-2-

bromoethan-1-one (0.8 g, 2.38 mmol), 2-ethyl pyrinine (0.255 g, 2.38
mmol) and 10 mL acetone. The mixture was heated to 60°C and stirred, during which a
white precipitate formed. After 16 hours, the solution was cooled to room temperature, and
the white precipitate was filtered off and washed with cold acetone. The precipitate was
then combined with sodium bicarbonate (0.802 g, 9.55 mmol) in a round bottom flask and
dissolved in 10 mL water. The solution was heated to 100°C and stirred for 2 hours. After
2 hours a brown oil had formed, and was extracted with dichloromethane. The organic
layer was washed three times with water, dried and concentrated to yield the pure product.
1

H NMR (300 MHz, CDCl3) δ 7.94 (s, 2 H), δ 7.87 (d, J = 6.9 Hz, 1 H), δ 7.79 (s, 1 H), δ

7.46 (s, 1 H), δ 7.35 (d, J = 9.03 Hz, 1 H), δ 6.67 (t, J = 6.7 Hz, 1 H), δ 6.48 (t, J = 6.7 Hz,
1 H), δ 2.43 (s, 3 H).

13

C NMR (300 MHz, CDCl3) δ 138.3, 131.9, 131.5, 131.4, 128.3,

126.1, 124.8, 117.7, 116.5, 110.9, 110.1, 105.6, 9.4.
IR (neat, cm-1): 3232 (br), 2923, 2866, 1617.
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(Z)-4-(2-(3,5-bis(trifluoromethyl)phenyl)-1-

CF3
F3 C

N

O

methyl-3H-indolizin-4-ium-3-ylidene)-2-(2-(3,5,CF3

O

N

bis(trifluoromethyl)phenyl)-1-methylindolizin-3yl)-3-oxocyclobut-1-en-1-olate (23): To a N2 filled,

F3 C

round bottom flask equipped with a stir bar and a reflux condenser was added (22) (0.235
g, 0.685 mmol), 3,4-dihydroxy-1,2-cyclobutanedione (0.0389 g, 0.342 mmol) and
dissolved in 40 mL 1:1 toluene:n-butanol. The mixture was heated to 130°C and stirred.
After 6 hours, the mixture was cooled to room temperature and 50 mL diethyl ether was
added to precipitate a dark solid. The liquid was decanted and the solids were collected. To
purify, the solids were dissolved in hot dichloroethane and filtered. The solution was
cooled at room temperature, and dark solids precipitated at the bottom of the flask with a
bright green solution. The solids were separated from the supernatant to yield the pure
metallic product. 1H NMR (300 MHz, CDCl3) δ 9.99 (d, J = 6.3 Hz, 2 H), δ 7.90 (s, 2 H),
δ 7.74 (s, 4 H), δ 7.45 (d, J = 8.61, 2 H), δ 7.30 (t, J = 7.59, 2 H), δ 6.98 (t, J = 6.72, 2 H),
δ 2.23 (s, 6 H). 13C NMR (300 MHz, CDCl3) will not dissolve into solution. IR (neat, cm1): 3415.25, 1573.58, 1556.24. UV-vis (CH2Cl2) λmax = 720 nm (ε = 260,205 M-1cm-1),
λonset = 746 nm.

Synthetic Procedures: NO2Ph-In-SQ
O2N

NO2
NO2
N

N

O

(b)

(a)

+

N

N

O

O
NO 2

Br

39

1-methyl-2-(4-nitrophenyl)indolizine (24): To a flame dried round bottom

NO 2

flask equipped with a stir bar and a reflux condenser was added 2-bromo-4’nitroacetophenone (1.0 g, 4.10 mmol) and 2-ethyl pyridine (0.439 g, 4.10
N

mmol) and dissolved in 16.4 mL acetone. The mixture was heated to 60°C and

stirred. After 16 hours, the solution was cooled to room temperature, and the white
precipitate was filtered off and washed with cold acetone. The precipitate was then
combined with sodium bicarbonate (1.38 g, 16.4 mmol) in a round bottom flask and
dissolved in 16.4 mL water. The solution was heated to 100°C and stirred for 2 hours. After
2 hours brown oil had formed, and was extracted with dichloromethane. The organic layer
was washed three times with water, dried with sodium sulfate and concentrated. To purify,
the product was filtered through silica with 1:1 dichloromethane:hexanes and concentrated
to yield a orange powder (0.237 g, 23%). 1H NMR (300 MHz, CDCl3) δ 8.27 (d, J = 8.7
Hz, 2 H), δ 7.86 (d, J = 6.8 Hz, 1 H), δ 7.67 (d, J = 8.7 Hz, 2 H), δ 7.46 (s, 1 H), δ 7.35, (d,
J = 9.2 Hz, 1 H), δ 6.66 (t, J = 6.7 Hz, 1 H), δ 6.47 (t, J = 6.5 Hz, 1 H), δ 2.46 (s, 3 H). 13C
NMR (300 MHz, CDCl3) δ 146.1, 143.2, 131.5, 128.7, 126.6, 124.8, 123.9, 117.8, 116.5,
111.0, 110.4, 105.9, 9.8. IR (neat, cm-1): 3361.25, 3108.63, 1594.81.

(Z)-4-(1-methyl-2-)4-nitrophenyl)-3H-indolizin-4-ium-

O2 N

3-ylidene)-2-)1-methyl-2-(4-nitrophenyl)indolizin-3-

N

O

yl)-3-oxocyclobut-1-en-1-olate (25): To a N2 filled round
N

O
NO 2

bottom flask equipped with a stir bar and a reflux

condenser was added (24) (0.118 g, 0.468 mmol), 3,4-dihydroxy-1,2-cyclobutanedione
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(0.027 g, 0.234 mmol) and dissolved in 13.4 mL toluene:n-butanol. The mixture was heated
to 130°C and stirred. After 24 hours the mixture was cooled to room temperature and 50
mL 1:1 diethyl ether:hexanes was added. A red solid precipitated and the liquid was
decanted off. The solids were recrystallized in dichloromethane and concentrated to yield
a metallic red solid (0.088 g, 64%). 1H NMR (300 MHz, CDCl3) δ 10.13 (d, J = 5.22, 2 H),
δ 8.28 (d, J = 8.58 Hz, 4 H), δ 7.46 (d, J = 8.85, 4 H), δ 7.43 (d, J = 9.93, 2 H), δ 7.23
(hidden by CDCl3), δ 6.45 (t, J = 6.45 Hz, 2 H), 2.18 (s, 6 H). 13C NMR (300 MHz, CDCl3)
δ will not dissolve into solution. IR (neat, cm-1): 3407.53, 1652.66, 1616.81. UV-vis
(CH2Cl2) λmax = 727 nm (ε = 184,515 M-1cm-1), λonset = 757 nm.

Synthetic Procedures: CNPh-In-SQ
CN

NC

CN
(b)

(a)

N

N

O

+

N

O

N

O
CN

Br

4-(1-methylindolizin-2-yl)benzonitrile (26): To a flame dried round bottom
CN

flask equipped with a stir bar and a reflux condenser was added 4-(2bromoacetyl)benzonitrile (0.5g, 2.23 mmol) and 2-ethylpyridine (0.256 mL,
N

2.23 mmol) and dissolved in 5 mL acetone. The mixture was then heated to 60°C
and stirred for 16 hours to yield a white precipitate. The reaction mixture was

then cooled to room temperature, and the precipitate was filtered off, rinsed with cold
acetone and dried. The solid was then dissolved in 5 mL H2O with sodium bicarbonate
(0.75 g, 8.93 mmol). The solution was heated to 100°C, during which a brown precipitate
41

formed. After 3 hours, the precipitate was extracted with 50 mL dichloromethane, washed
3 times with water, dried with magnesium sulfate and condensed to yield a dark brown
solid (0.283 g, 54%). 1H NMR (300 MHz, CDCl3) δ 7.85 (d, J = 6.93 Hz, 1 H), δ 7.70 (d,
J = 8.55 Hz, 2 H), δ 7.62 (d, J = 8.34 Hz, 2 H), δ 7.42 (s, 1 H), δ 7.34 (d, J = 9.03 Hz, 1
H), δ 6.65 (t, J = 6.00 Hz, 1 H), δ 6.46 (t, J = 6.66 Hz, 1 H), δ 2.43 (s, 1 H). 13C NMR (300
MHz, CDCl3) δ 141.07, 132.28, 131.42, 128.84, 127.03, 124.85, 119.34, 117.73, 116.93,
110.88, 110.24, 109.48, 105.69, 9.81. IR (neat, cm-1): 3100, 2912, 2842, 2219.

(Z)-4-(2-(4-cyanophenyl)-1-methyl-3H-indolizin-4-ium-

NC
N

O

N

3-ylidene)-2-(2-(4-cyanophenyl)-1-methylindolizin-3-yl)3-oxocyclobut-1-en-1-olate (27): To a flame dried, N2

O
CN

flushed round bottom flask was added (17) (0.153 g, 0.659

mmol) and 3,4-dihydroxy-1,2-cyclobutanedione (0.037 g, 0.33 mmol), and flushed with
N2 for 10 minutes, then dissolved in 38 mL 1:1 toluene:n-butanol. The reaction mixture
was heated to 130°C with a reflux condenser for 2.5 hours, during which a green solid
precipitated. The precipitate was extracted with dichloromethane, then condensed. To
purify, the solid was recrystallized in hexanes three times, then suspended in diethyl ether
and centrifuged. The resulting supernatant was decanted off to yield a metallic green solid
(0.23g, 46%). 1H NMR (300 MHz, CDCl3) δ 10.12 (d, J = 7.0 Hz, 2 H), δ 7.72 (d, J = 8.3
Hz, 4 H), δ 7.41 (d, J = 8.25, 6 H), δ 7.27 (t, J = 6.85 Hz, 2 H), δ 6.96 (t, J = 5.6 Hz, 2 H),
δ 2.17 (s, 6 H). 13C NMR will not dissolve into solution. IR (neat, cm-1): 3390, 2913, 2846,
2373, 2346, 2217, 1604, 1596. UV-vis (CH2Cl2) λmax = 723 nm (ε = 213,492 M-1cm-1),
λonset = 753 nm.
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NMR Data.
1H

NMR: 1,2-dimethylindolizine (1)

1H

NMR: (Z)-4-(1,2-dimethyl-3H-indolizin-4-ium-3-ylidene)-2-(1,2dimethylindolizin-3-yl)-3-oxocyclobut-1-en-1-olate (2)

43

1H

NMR: (Z)-4-(1-methyl-2-phenyl-3H-indolizin-4-ium-3-ylidene)-2-(1-methyl-2phenylindolizin-3-yl)-3-oxocyclobut-1-en-1-olate (5)

13C

NMR: (Z)-4-(1-methyl-2-phenyl-3H-indolizin-4-ium-3-ylidene)-2-(1-methyl-2phenylindolizin-3-yl)-3-oxocyclobut-1-en-1-olate (5)

44

1H

NMR: 2-bromo-1-mesitylethanone (6)

1H

NMR: 2-mesityl-1-methylindolizine (7)
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1H

NMR: (Z)-4-(2-mesityl-1-methyl-3H-indolizin-4-ium-3-ylidene)-2-(2-mesityl-1methylindolizin-3-yl)-3-oxocyclobut-1-en-1-olate) (8)

1H

NMR: 1-methyl-2-(naphthalene-2-yl)indolizine (9)
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13C

NMR: 1-methyl-2-(naphthalene-2-yl)indolizine (9)

1H

NMR: (Z)-4-(1-methyl-2-(naphthaneln-2-yl)-3H-indolizin-4-ium-3-ylidene)-2-(1methyl-2-(naphthalene-2-yl)indolizin-3-yl)-3-oxocyclobut-1-en-1-olate (10)
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1H

NMR: 2-bromo-1-(pyren-4-yl)ethanone (11)

1H

NMR: 1-methyl-2-(pyren-2-yl)indolizine (12)

48

1H

NMR: (Z)-4-(1-methyl-2-(pyren-2-yl)-3H-indolizin-4-ium-3-ylidene)-2-(1-methyl2-pyren-2-yl)indolizin-3-yl)-oxocyclobut-1-en-1-olate (13)

1H

NMR: 2-(4-methoxyphenyl)-1-methylindolizine (14):
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1H

NMR: (Z)-4-(2-(4-methoxyphenyl)-1-methyl-3H-indolizin-4-ium-3-ylidene)-2-(2(4-methoxyphenyl)-1-methylindolizin-3-yl)-3-oxocyclobut-1-en-1-olate (15)

13C

NMR: (Z)-4-(2-(4-methoxyphenyl)-1-methyl-3H-indolizin-4-ium-3-ylidene)-2(2-(4-methoxyphenyl)-1-methylindolizin-3-yl)-3-oxocyclobut-1-en-1-olate (15)
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1H

NMR: 4-(1-methylindolizin-2-yl)phenol (16)

13C

NMR: 4-(1-methylindolizin-2-yl)phenol (16)
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1H

NMR: (Z)-4-(2-(4-hydroxyphenyl)-1-methyl-3H-indolizin-4-ium-3-ylidene)-2-(2(4-hydroxyphenyl)-1-methylindolizin-3-yl)-3-oxocyclobut-1-en-1-olate (17)

1H

NMR:2,6-di-tert-butyl-4-(1-methylindolizin-2-yl)phenol (18)

52

13C

1H

NMR:2,6-di-tert-butyl-4-(1-methylindolizin-2-yl)phenol (18)

NMR:1-methyl-2-(4trifluoromethyl)phenyl)indolizine (20)
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13C

NMR:1-methyl-2-(4trifluoromethyl)phenyl)indolizine (20)

1H

NMR: (Z)-4-(1-methyl-2-(4-(trifluoromethyl)phenyl)-3H-indolizin-4-ium-3ylidene)-2-(1-methyl-2-(4-trifluoromethyl)phenyl)indolizin-3-yl)-3-oxocyclobut-1-en1-olate (21)

54

1H

NMR: 2-(3,5-bis(trifluoromethyl)phenyl)-1-methylindolizine (22)

13C

NMR: 2-(3,5-bis(trifluoromethyl)phenyl)-1-methylindolizine (22)
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1H

NMR: (Z)-4-(2-(3,5-bis(trifluoromethyl)phenyl)-1-methyl-3H-indolizin-4-ium-3ylidene)-2-(2-(3,5,-bis(trifluoromethyl)phenyl)-1-methylindolizin-3-yl)-3oxocyclobut-1-en-1-olate (23)

1H

NMR: 1-methyl-2-(4-nitrophenyl)indolizine (24)
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13C

NMR: 1-methyl-2-(4-nitrophenyl)indolizine (24)

1H

NMR: (Z)-4-(1-methyl-2-)4-nitrophenyl)-3H-indolizin-4-ium-3-ylidene)-2-)1methyl-2-(4-nitrophenyl)indolizin-3-yl)-3-oxocyclobut-1-en-1-olate (25)
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1H

NMR: (Z)-4-(2-(4-cyanophenyl)-1-methyl-3H-indolizin-4-ium-3-ylidene)-2-(2-(4cyanophenyl)-1-methylindolizin-3-yl)-3-oxocyclobut-1-en-1-olate (27)
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